Literature DB >> 26863889

Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).

Chris Brough1,2, Dave A Miller3, Daniel Ellenberger4,3, Dieter Lubda5, Robert O Williams4.   

Abstract

The KinetiSol® Dispersing (KSD) technology has enabled the investigation into the use of polyvinyl alcohol (PVAL) as a concentration enhancing polymer for amorphous solid dispersions. Our previous study revealed that the 88% hydrolyzed grade of PVAL was optimal for itraconazole (ITZ) amorphous compositions with regard to solid-state properties, non-sink dissolution performance, and bioavailability enhancement. The current study investigates the influence of molecular weight for the 88% hydrolyzed grades of PVAL on the properties of KSD processed ITZ:PVAL amorphous dispersions. Specifically, molecular weights in the processable range of 4 to 18 mPa · s were evaluated and the 4-88 grade provided the highest AUC dissolution profile. Amorphous dispersions at 10, 20, 30, 40, and 50% ITZ drug loads in PVAL 4-88 were also compared by dissolution performance. Analytical tools of diffusion-ordered spectroscopy and Fourier transform infrared spectroscopy were employed to understand the interaction between drug and polymer. Finally, results from a 30-month stability test of a 30% drug loaded ITZ:PVAL 4-88 composition shows that stable amorphous dispersions can be achieved. Thus, this newly enabled polymer carrier can be considered a viable option for pharmaceutical formulation development for solubility enhancement.

Entities:  

Keywords:  PVAL; amorphous solid dispersion; itraconazole; polyvinyl alcohol; solubility enhancement

Mesh:

Substances:

Year:  2016        PMID: 26863889      PMCID: PMC4766124          DOI: 10.1208/s12249-016-0490-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  44 in total

Review 1.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

Authors:  Chau Le-Ngoc Vo; Chulhun Park; Beom-Jin Lee
Journal:  Eur J Pharm Biopharm       Date:  2013-09-18       Impact factor: 5.571

2.  Moving-window two-dimensional correlation infrared spectroscopic study on the dissolution process of poly(vinyl alcohol).

Authors:  Bai Xue; Junhua Zhang; Tao Zhou
Journal:  Anal Bioanal Chem       Date:  2015-10-14       Impact factor: 4.142

3.  Evaluation of the microstructure of semicrystalline solid dispersions.

Authors:  Qing Zhu; Lynne S Taylor; Michael T Harris
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.

Authors:  Randy Mellaerts; Raf Mols; Jasper A G Jammaer; Caroline A Aerts; Pieter Annaert; Jan Van Humbeeck; Guy Van den Mooter; Patrick Augustijns; Johan A Martens
Journal:  Eur J Pharm Biopharm       Date:  2007-11-23       Impact factor: 5.571

5.  Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier.

Authors:  Justin R Hughey; Justin M Keen; Dave A Miller; Chris Brough; James W McGinity
Journal:  Int J Pharm       Date:  2012-08-31       Impact factor: 5.875

6.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.

Authors:  Karel Six; Hugo Berghmans; Christian Leuner; Jennifer Dressman; Kristof Van Werde; Jules Mullens; Luc Benoist; Mireille Thimon; Laurent Meublat; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

7.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Authors:  L Mu; S S Feng
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

8.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

9.  Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.

Authors:  Keru Zhang; Hongxia Yu; Qing Luo; Shenshen Yang; Xia Lin; Yu Zhang; Bin Tian; Xing Tang
Journal:  Eur J Pharm Biopharm       Date:  2013-04-03       Impact factor: 5.571

10.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.

Authors:  Geert Verreck; Karel Six; Guy Van den Mooter; Lieven Baert; Jef Peeters; Marcus E Brewster
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  4 in total

1.  Pharmaceutical Thermal Processing.

Authors:  Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2016-02-09       Impact factor: 3.246

2.  Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.

Authors:  Kamil Wlodarski; Feng Zhang; Tongzhou Liu; Wieslaw Sawicki; Thomas Kipping
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Transdermal Delivery of Kidney-Targeting Nanoparticles Using Dissolvable Microneedles.

Authors:  Nirmalya Tripathy; Jonathan Wang; Madelynn Tung; Claire Conway; Eun Ji Chung
Journal:  Cell Mol Bioeng       Date:  2020-06-01       Impact factor: 2.321

Review 4.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.